Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study
Duruisseaux, Michaël, Besse, Benjamin, Cadranel, Jacques, Pérol, Maurice, Mennecier, Bertrand, Bigay-Game, Laurence, Descourt, Renaud, Dansin, Eric, Audigier-Valette, Clarisse, Moreau, Lionel, HureauxVolume:
8
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.15746
Date:
March, 2017
File:
PDF, 2.71 MB
english, 2017